DEC ~ 1 2004
510(k) Summary of Safety and Effectiveness forthe L< 0414 v7
Diomed, Inc. EVLT Kit and D15Plus and D30Plus Lasers
This 510(k) Summary of Safety and Effectiveness is being submitted in accordance with
the requirements of the SMDA 1990 and 21 CFR 807.92.
1. General Information
Submitter: Diomed, Inc.
One Dundee Park, Suites 5 and 6
P.O. Box 97
Andover, MA 01810
Contact Person: Maureen O’Connell
5 Timber Lane
North Reading, MA 01864
Telephone: 978-207-1245
Fax: 978-207-1246
Summary Preparation Date: November 16, 2004
2. Names
Device Name: EVI.T Kit and D15Plus and D30Plus Lasers
Classification Name: Laser Instrument, Surgical Powered
Product Code: GEX
Panel: Dermatology and Plastic Surgery
3. Predicate Devices
a
The EVLT Kit and the D15Plus and D30Plus Lasers are substantially equivalent to
the Diomed EVLT Kit and D15Plus and D30Plus Diode Lasers (K023543), the
Diomed 810 nm Surgical Lasers and EVLT Procedure Kit (K012398) and the
Diomed 15Plus and Diomed 30Plus Lasers (K013499).
4. Device Description
The DIOMED 15 Plus is a diode laser capable of delivering up to 119 J/cm’ of
pulsed radiation via a fiber optic handpiece or 0.5-15 W of continuous wave
radiation via an optical fiber coupled to the laser aperture. The DIOMED 30 Plus
is a diode laser capable of delivering up to 400 J/cm? of pulsed radiation via a fiber
optic handpiece or 0.5-30 W of continuous wave radiation via an optical fiber
coupled to the laser aperture.

An EVLT procedure kit is available which may contains a 400 -1000 micron core,
2.5 meter long bare tip fiber with location markers, a 25-100 cm long, 4- 5 Fr
graduated introducer sheath with dilator, a 19 Gauge, 7 cm percutaneous entry
needle, and a 0.035” J guide wire.
5. Indications for Use
The 810nm Diomed Laser and EVLT Procedure Kit are intended for use in the
treatment of superficial vein reflux of the greater saphenous vein associated with
varicosities. The Diomed D15 plus and D30 plus and EVLT Kits are indicated for
treatment of incompetence and reflux of superficial veins in the lower extremity.
6. Performance Data
Clinical data was presented on 213 subjects treated with endovenous laser
treatment with the Diomed D15Plus Laser System and EVLT Kit.

‘ 7s
i & DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
a
Food and Drug Administration
9200 Corporate Boulevard
Rockville MD 20850
Diomed Inc. DEC - 1 2004
C/o Ms. Maureen O’Connell
Regulatory Consultant
5 Timber Lane
North Reading, Massachusetts 01864
Re: K041957 /
Trade/Device Name: EVLT Kit and D15 Plus and D30 Plus Laser Systems
Regulation Number: 21 CFR 878.4810
Regulation Name: Laser surgical instrument for use in general and plastic surgery and in
dermatology
Regulatory Class: I
Product Code: GEX
Dated: October 15, 2004
Received: October 18, 2004
Dear Ms. O’Connell:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing Q)
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act), 21 CFR 1000-1050.

Page 2 - Ms. Maureen O’Connell
This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled,
"Misbranding by reference to premarket notification” (21CFR Part 807.97). You may obtain
other general information on your responsibilities under the Act from the Division of Small
Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or
(301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html

Sincerely yours,

(Celia M. Witten, Ph.D., M.D.
Director
Division of General, Restorative
and Neurological Devices
Office of Device Evaluation
Center for Devices and
Radiological Health

Enclosure

Indications for Use
510(k) Number (if known): —K041957
Device Name: EVLT Kit and D15 Plus and D30 Plus Laser Systems
Indications For Use:
The 810nm Diomed Laser and EVLT Procedure Kit are intended for use in the treatment of
superficial vein reflux of the greater saphenous vein associated with varicosities. The Diomed D15
plus and D30 plus and EVLT Kits are indicated for treatment of incompetence and reflux of
superficial veins in the fower extremity.
Prescription Use x AND/OR Over-The-Counter Use
(Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE

IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

(Division Sign-Off) oo

Division of General, Restorative,

and Neurological Devices

Page lof 1
510k) Number__KO4737__

